✦ LIBER ✦

1184 CHARACTERIZATION OF HCV VARIANTS IN GENOTYPE 1 TREATMENT-NAIVE PATIENTS ADMINISTERED THE COMBINATION OF TVR AND VX-222 IN DUAL ARMS OF ZENITH STUDY

✍ Scribed by Zhang, E.Z.; Tigges, A.; Jiang, M.; Dorrian, J.; Spanks, J.; Ardzinski, A.; Alves, K.; De Souza, C.; Bartels, D.J.; Koziel, M.J.; Bisceglie, A.M. Di; Kieffer, T.L.

Book ID: 123181598
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 74 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61196-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

31 SAFETY AND ANTIVIRAL ACTIVITY OF THE

31 SAFETY AND ANTIVIRAL ACTIVITY OF THE HCV NON-NUCLEOSIDE POLYMERASE INHIBITOR VX-222 IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS

✍ M. Rodriguez-Torres; E. Lawitz; B. Conway; K. Kaita; A.M. Sheikh; R. Ghalib; R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

1210 PRE-EXISTENCE, EMERGENCE AND PERSIS

1210 PRE-EXISTENCE, EMERGENCE AND PERSISTENCE OF HCV GENOTYPE 4 NS5A RESISTANCE VARIANTS FROM THE PHASE 2B COMMAND-1 STUDY: DACLATASVIR PLUS PEGINTERFERON-alfa/ RIBAVIRIN IN TREATMENT-NAIVE PATIENTS

✍ McPhee, F.; Zhou, N.; Ueland, J.; Yu, F.; Yang, X.; Monikowski, A.; Kirk, M.; Hu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB